drugset / Trial / NCT00162786

Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance

NCT00162786

Phase 4 Terminated 20 enrolled J. Uriach and Company
RandomizedCrossoverDouble-blindPrevention

Summary

The primary objective of this study is to measure and compare the acute effects of rupatadine 10 mg, relative to placebo and hydroxyzine 50 mg as an active control on healthy volunteers' performance on a standard over-the-road driving test and a car-following test.

Timeline

Start
2005-05
Primary completion
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxyzine Small molecule 50 mg
Subject Rupatadine Small molecule 10 mg

Indications

No indication recorded.